Amrize Ltd (NYSE:AMRZ – Get Free Report) insider Mario Gross acquired 1,200 shares of Amrize stock in a transaction that occurred on Wednesday, May 20th. The shares were purchased at an average price of $48.63 per share, for a total transaction of $58,356.00. Following the transaction, the insider directly owned 34,747 shares in the company, valued at $1,689,746.61. The trade was a 3.58% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Mario Gross also recently made the following trade(s):
- On Tuesday, May 19th, Mario Gross bought 2,800 shares of Amrize stock. The stock was purchased at an average price of $49.17 per share, with a total value of $137,676.00.
- On Friday, March 13th, Mario Gross purchased 3,200 shares of Amrize stock. The shares were purchased at an average cost of $55.29 per share, for a total transaction of $176,928.00.
Amrize Stock Performance
NYSE:AMRZ opened at $50.55 on Friday. The stock’s 50-day moving average is $54.95 and its 200-day moving average is $55.12. Amrize Ltd has a 1-year low of $44.12 and a 1-year high of $65.94. The company has a current ratio of 1.40, a quick ratio of 0.89 and a debt-to-equity ratio of 0.38. The stock has a market cap of $27.96 billion and a P/E ratio of 24.19.
Amrize Cuts Dividend
The firm also recently disclosed a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were paid a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s payout ratio is currently 21.05%.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of AMRZ. Norges Bank acquired a new stake in Amrize in the fourth quarter worth $929,333,000. Harris Associates L P acquired a new stake in Amrize in the fourth quarter valued at approximately $615,406,000. Vanguard Group Inc. increased its holdings in shares of Amrize by 41.0% during the third quarter. Vanguard Group Inc. now owns 30,094,083 shares of the company’s stock valued at $1,468,460,000 after acquiring an additional 8,743,543 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Amrize by 48.8% during the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after acquiring an additional 3,809,133 shares in the last quarter. Finally, Marshall Wace LLP raised its position in shares of Amrize by 865.4% during the third quarter. Marshall Wace LLP now owns 2,889,660 shares of the company’s stock worth $139,436,000 after purchasing an additional 2,590,336 shares during the period.
Analysts Set New Price Targets
AMRZ has been the subject of several analyst reports. Stephens restated an “overweight” rating and set a $65.00 price target on shares of Amrize in a report on Monday. Berenberg Bank set a $70.00 price objective on shares of Amrize in a research note on Thursday, February 19th. Citigroup lowered their target price on shares of Amrize from $76.00 to $66.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Wells Fargo & Company dropped their target price on shares of Amrize from $66.00 to $65.00 and set an “overweight” rating on the stock in a report on Wednesday, April 15th. Finally, Royal Bank Of Canada cut their price target on shares of Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a research report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $64.86.
Get Our Latest Stock Report on AMRZ
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories
- Five stocks we like better than Amrize
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
- Intuit’s Great SaaS Reset: Fired By AI
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
